Syed Agha, MD
Interventional Cardiology · Cleveland, TNNPI 1164420741
Payments from drug & device makers
Across 514 payments — averaging $38.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardiovascular Systems Inc.$5K
- Medtronic$5K
- Abbott$2K
- Novartis$1K
- AstraZeneca$1K
- Boston Scientific$1K
- plus $4K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardiovascular Systems Inc. | 30 | $5,143 |
| Medtronic(2 entities) | 111 | $4,731 |
| Abbott | 61 | $2,304 |
| Novartis | 81 | $1,381 |
| AstraZeneca | 27 | $1,352 |
| Boston Scientific | 26 | $1,285 |
| Actelion Pharmaceuticals US, Inc. | 27 | $890 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 31 | $437 |
| E.r. Squibb & Sons, L.L.C. | 25 | $313 |
| Shockwave Medical, Inc | 7 | $294 |
| Johnson & Johnson | 16 | $280 |
| Amgen | 15 | $275 |
| Boehringer Ingelheim | 15 | $266 |
| Inari Medical, Inc. | 1 | $132 |
| Baxter Healthcare | 2 | $122 |
| Merck | 6 | $119 |
| Novo Nordisk | 5 | $88 |
| Pfizer | 5 | $87 |
| Scpharmaceuticals Inc. | 4 | $87 |
| Penumbra, Inc. | 3 | $53 |
| Chiesi USA, Inc. | 2 | $45 |
| Amarin Pharma, Inc. | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Abiomed | 1 | $22 |
| Cvrx, Inc. | 1 | $21 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $21 |
| Angiodynamics, Inc. | 1 | $20 |
| Bayer | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Philips North America LLC | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Lantheus Medical Imaging, Inc. | 1 | $15 |
| Irhythm Technologies, Inc. | 1 | $15 |
| Cashflow Solutions, LLC | 1 | $14 |
How this compares
$19,946 in reported general payments places this provider in the 70th percentile of 207 interventional cardiology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Cleveland
- Michael MorseNashville$3.5M
- Charles TreasurePowell$3M
- Colin BarkerNashville$2.1M
- Brian JeffersonNashville$2.1M
- Malcolm FosterKnoxville$1.9M
- Rahul SakhujaKingsport$1.9M
- Kashish GoelNashville$1.1M
- Samuel HorrNashville$912K
- Mehul PatelGermantown$810K
- Jimmy KerriganNashville$769K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.